Organigram Reports Record Fourth Quarter and Fiscal 2025 Results

About this update from Organigram Global Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/6b470e617f5ea0189b19c51894c71c31"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/maEXLQevdfD7dmkyTiojGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6b470e617f5ea0189b19c51894c71c31","width":480,"height":480}},"lazy":false},{"type":"text","content":"Record annual revenue, adjusted EBITDA1, and international sales.","length":65,"tagName":"p","attribs":{}},{"type":"text","content":"TORONTO, December 16, 2025--(BUSINESS WIRE)--Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 ("Q4 Fiscal 2025" or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$").","length":468,"tagName":"p"},{"type":"text","content":"FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS","length":40,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Gross Revenue: $123.3 million (+76% year-over-year).","length":52,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net Revenue: $80.1 million (+79% year-over-year).","length":49,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted Gross Margin1: $30.6 million or 38%.","length":45,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA1: $9.8 million (+69% year-over-year).","length":53,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":199,"olType":false},{"type":"text","content":"FISCAL 2025 FINANCIAL HIGHLIGHTS","length":32,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Gross Revenue: $403.0 million (+63% year-over-year).","length":52,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net Revenue: $259.2 million (+62% year-over-year).","length":50,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted Gross Margin1: $91.0 million or 35%.","length":45,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBI...

More updates from Organigram Global Inc.